Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy
about
Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumoursSimvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and NeckLocally advanced rectal cancer: a comparison of management strategies.The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy.Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies.Development and characterization of an isogenic cell line with a radioresistant phenotype.Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells.
P2860
Q34283737-102DEC66-38C1-4249-8D02-8F05CC34718DQ34369305-219DDA4A-2464-423D-830E-14E596FD4639Q37895253-B059C4EE-BD30-4973-97A5-8771CB9BFC14Q37904839-5D8E7B11-5E7B-4CF3-A2DB-36F7248BCDB8Q38155932-5297A760-1EEA-4DA2-BBE9-4A28DA6036DFQ39004424-906CE05F-5319-41E8-9FA2-63B591ACBF81Q39110385-5DB29FDF-A3A9-4D60-B904-A4F128C76FCCQ39303897-EB2A76E2-80DC-4119-B69E-5B055DB9C95EQ39517299-5029968D-6256-4174-961B-7FD9C31526B1Q39628198-EB4CEE22-0029-4F5C-9396-1B58580564C1
P2860
Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cetuximab may inhibit tumor gr ...... e treatment after radiotherapy
@en
Cetuximab may inhibit tumor gr ...... treatment after radiotherapy.
@nl
type
label
Cetuximab may inhibit tumor gr ...... e treatment after radiotherapy
@en
Cetuximab may inhibit tumor gr ...... treatment after radiotherapy.
@nl
prefLabel
Cetuximab may inhibit tumor gr ...... e treatment after radiotherapy
@en
Cetuximab may inhibit tumor gr ...... treatment after radiotherapy.
@nl
P2093
P2860
P1433
P1476
Cetuximab may inhibit tumor gr ...... e treatment after radiotherapy
@en
P2093
Agnes Figueras
Alicia Lozano
Gemma Pueyo
Josep Balart
Ricard Mesia
Silvia Vazquez
P2860
P304
P356
10.1634/THEONCOLOGIST.2008-0290
P577
2010-08-26T00:00:00Z